Literature DB >> 14718210

Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.

Bertram Price1, Adam Ware.   

Abstract

Using 1973-2000 mesothelioma incidence data released by the Surveillance, Epidemiology, and End Results Program in April 2003, the authors estimated the parameters of a birth-cohort and age model to determine whether previously reported patterns of mesothelioma in the United States have changed. Compared with analyses based on data through 1992, a slower decline was found in male cases immediately after a peak in 2000-2004, but no other notable changes in the time pattern were detected. Analysis confirmed that the annual number of male mesothelioma cases, which increased steeply from the 1970s through the mid-1990s, has leveled off in terms of both the age-adjusted rate and the absolute numbers of cases. After a peak of approximately 2,000 cases, a return to background levels is expected by 2055. The total projected number of male mesothelioma cases in 2003-2054 is approximately 71,000. The maximum lifetime risk for males, which occurs for the 1925-1929 birth cohort, is 1.8 x 10(-3). The age-adjusted rate for females is constant, as are the female lifetime mesothelioma risk across birth cohorts (3.6 x 10(-4)) and the annual risk (3.9 x 10(-6)). The time pattern of cases for females supports the existence of a threshold exposure for mesothelioma and a quantifiable background rate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718210     DOI: 10.1093/aje/kwh025

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  73 in total

1.  Treatment failure after extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Tristan D Yan; Momo Tin; Michael Boyer; Jocelyn McLean; Paul G Bannon; Brian C McCaughan
Journal:  J Thorac Dis       Date:  2009-12       Impact factor: 2.895

2.  Severe case of asbestos-related lung diseases.

Authors:  Pichapong Tunsupon; Pojchawan Yampikulsakul
Journal:  BMJ Case Rep       Date:  2016-01-28

Review 3.  Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.

Authors:  Roberto E Favoni; Antonio Daga; Paolo Malatesta; Tullio Florio
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Malignant pleural mesothelioma treated in Clinic for Pulmonary Diseases and Tuberculosis "Podhrastovi" in ten-year period (from 1998 to 2007).

Authors:  Vesna Cukić; Aida Ustamujić; Vladimir Lovre; Hasan Zutić; Sadika Genjac; Mina Masić-Zecević
Journal:  Bosn J Basic Med Sci       Date:  2008-11       Impact factor: 3.363

5.  Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis.

Authors:  Deepa Magge; Mazen S Zenati; Frances Austin; Arun Mavanur; Magesh Sathaiah; Lekshmi Ramalingam; Heather Jones; Amer H Zureikat; Matthew Holtzman; Steven Ahrendt; James Pingpank; Herbert J Zeh; David L Bartlett; Haroon A Choudry
Journal:  Ann Surg Oncol       Date:  2013-12-10       Impact factor: 5.344

6.  A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma.

Authors:  Stephanie R Rice; Yun R Li; Theresa M Busch; Michele M Kim; Sally McNulty; Andrea Dimofte; Timothy C Zhu; Keith A Cengel; Charles B Simone
Journal:  Photochem Photobiol       Date:  2018-12-28       Impact factor: 3.421

7.  Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008.

Authors:  S Jane Henley; Theodore C Larson; Manxia Wu; Vinicius C S Antao; Mary Lewis; Germania A Pinheiro; Christie Eheman
Journal:  Int J Occup Environ Health       Date:  2013 Jan-Mar

8.  The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.

Authors:  Aatur D Singhi; Alyssa M Krasinskas; Haroon A Choudry; David L Bartlett; James F Pingpank; Herbert J Zeh; Alyssa Luvison; Kimberly Fuhrer; Nathan Bahary; Raja R Seethala; Sanja Dacic
Journal:  Mod Pathol       Date:  2015-10-23       Impact factor: 7.842

9.  Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma.

Authors:  H Richard Alexander; David L Bartlett; James F Pingpank; Steven K Libutti; Richard Royal; Marybeth S Hughes; Matthew Holtzman; Nader Hanna; Keli Turner; Tatiana Beresneva; Yue Zhu
Journal:  Surgery       Date:  2013-03-13       Impact factor: 3.982

10.  Are current or future mesothelioma epidemics in Hong Kong the tragic legacy of uncontrolled use of asbestos in the past?

Authors:  Lap Ah Tse; Ignatius Tak-sun Yu; William Goggins; Mark Clements; Xiao Rong Wang; Joseph Siu-kie Au; Kai Shing Yu
Journal:  Environ Health Perspect       Date:  2009-10-22       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.